Pubblicazioni

HOME CARE ADMINISTRATION OF SUBCUTANEOUS AZACITIDINE (AZA) AND DOMICILIARY MANAGEMENT OF FRAIL PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA/MYELODYSPLASTIC SYNDROME: A FEASIBILITY STUDY

2016 - HAEMATOLOGICA

Cartoni, C; Carmosino, I; Brunetti, Ga; Latagliata, R; Minotti, C; Palumbo, G; Morano, Sg; Grammatico, S; Annechini, G; Breccia, M; Mandelli, F; Foa, R

EFFICACY AND SAFETY OF FIRST-LINE TREATMENT WITH NILOTINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS

2016 - HAEMATOLOGICA

Gugliotta, G; Castagnetti, F; Breccia, M; D'Adda, M; Stagno, F; Levato, L; Carella, Am; Martino, B; Tiribelli, M; Rege-Cambrin, G; Gozzini, A; Salvucci, M; Cedrone, M; Trabacchi, E; Usala, E; Scortechini, Ar; Luciano, L; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

SAFETY AND EFFICACY OF RUXOLITINIB IN CLINICAL PRACTICE FOR PRIMARY AND SECONDARY MYELOFIBROSIS

2016 - HAEMATOLOGICA

Breccia, M; Andriani, A; Montanaro, M; Abruzzese, E; Buccisano, F; Cedrone, M; Centra, A; Villiva, N; Celesti, F; Trawinska, Mm; Di Veroli, A; Anaclerico, B; Colafigli, G; Spadea, A; Petriccione, L; Cimino, G; Latagliata, R; Alimena, G

THE EUTOS LONG-TERM SURVIVAL SCORE IS PREDICTIVE FOR RESPONSE AND OUTCOME IN CML PATIENTS TREATED FRONTLINE WITH NILOTINIB-BASED REGIMENS

2016 - HAEMATOLOGICA

Castagnetti, F; Gugliotta, G; Breccia, M; Stagno, F; D'Adda, M; Levato, L; Carella, Am; Martino, B; Tiribelli, M; Fava, C; Binotto, G; Avanzini, P; Bocchia, M; Bergamaschi, M; Russo-Rossi, A; Cavazzini, F; Abruzzese, E; Soverini, S; Alimena, G; Cavo, M; Martinelli, G; Pane, F; Saglio, G; Baccarani, M; Rosti, G

MEANING OF MOLECULAR RESPONSES FLUCTUATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LONG-TERM IMATINIB

2016 - HAEMATOLOGICA

Breccia, M; Molica, M; Colafigli, G; Quattrocchi, L; Saracino, R; Latagliata, R; Mancini, M; Diverio, D; Alimena, G

2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS

2016 - HAEMATOLOGICA

Breccia, M; Pregno, P; Annunziata, M; Orlandi, E; Gozzini, A; Iurlo, A; Bocchia, M; Franceschini, L; Montefusco, E; Crugnola, M; La Nasa, G; Scortechini, Ar; Sgherza, N; Sica, S; Alimena, G; Saglio, G; Specchia, G

Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.

2015 - HAEMATOLOGICA

Falchi, M; Varricchio, L; Martelli, F; Masiello, F; Federici, Giulia; Zingariello, M; Girelli, Gabriella; Whitsett, C; Petricoin, Ef; Moestrup, Sk; Zeuner, A; Migliaccio, A. R.

Multifunctional human CD56low CD16low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.

2015 - HAEMATOLOGICA

Stabile, MARIA HELENA; Nisti, Paolo; Morrone, Stefania; Pagliara, D; Bertaina, A; Locatelli, F; Santoni, Angela; Gismondi, Angela

Response to comment on multifunctional human CD56<sup>low</sup>CD16<sup>low</sup> NK cells are the prominent subset in bone marrow of both pediatric healthy donors and leukemic patients

2015 - HAEMATOLOGICA

Stabile, MARIA HELENA; Nisti, Paolo; Pagliara, Daria; Locatelli, Franco; Santoni, Angela; Gismondi, Angela

The pan-class I PI3 kinase inhibitor, NVP-BKM120, demonstrates anti-leukemic activity in acute myeloid leukemia

2015 - HAEMATOLOGICA

Allegretti, Matteo; Ricciardi, Maria Rosaria; Licchetta, Roberto; Mirabilii, Simone; Orecchioni, Stefania; Reggiani, Francesca; Talarico, Giovanna; Foa, Roberto; Bertolini, Francesco; Amadori, Sergio; Tafuri, Agostino

TPO-RECEPTOR AGONISTS AS TREATMENT PREPARING ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA TO SPLENECTOMY. RESULTS OF A RETROSPECTIVE, OBSERVATIONAL STUDY (GIMEMA ITP0614)

2015 - HAEMATOLOGICA

Zaja, F; Barcellini, W; Cantoni, S; Carpenedo, M; Caparrotti, G; Carrai, V; Di Renzo, N; Santoro, Cristina; Di Nicola, M; Veneri, D; Simonetti, F; Liberati, Am; Ferla, V; Paoloni, F; Crea, E; Tuniz, E; Fanin, R.

THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS AFFECTED BY PRIMARY IMMUNE THROMBOCYTOPENIA: ANALYSIS OF POSSIBLE PREDICTIVE FACTORS FOR SUSTAINED AND DURABLE RESPONSE FROM A RETROSPECTIVE CASE SERIES

2015 - HAEMATOLOGICA

Santoro, Cristina; De Angelis, F; Baldacci, Erminia; Abbruzzese, R; Barone, Francesco; Bochicchio, Ar; Chisini, Marta; Ferrara, G; Mattone, Pf; Volpicelli, P; Foa, Roberto; Mazzucconi, Maria Gabriella

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Avvisati, G; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Ferrara, G; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, G; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella

SPLEEN ENLARGEMENT IS A RISK FACTOR FOR THROMBOSIS IN ESSENTIAL THROMBOCYTHEMIA: EVALUATION ON 1097 PATIENTS AND VALIDATION ON 792 PATIENTS

2015 - HAEMATOLOGICA

Andriani, A; Latagliata, R; Anaclerico, B; Spadea, A; Rago, A; Di Veroli, A; Spirito, F; Porrini, R; De Muro, M; Leonetti, Sc; Villiva, N; De Gregoris, C; Montefusco, E; Polverelli, N; Santoro, Cristina; Breccia, M; Cimino, Giuseppe; Majolino, I; Mazzucconi, Maria Gabriella; Vianelli, N; Alimena, G; Montanaro, M; Palandri, F.

OUTCOMES OF 65 PREGNANCIES IN 34 WOMEN WITH 5 DIFFERENT FORMS OF INHERITED PLATELET FUNCTION DISORDERS ENROLLED IN A RETROSPECTIVE AND MULTICENTRIC STUDY

2015 - HAEMATOLOGICA

Noris, P; Civaschi, E; Klersy, C; Melazzini, F; Pujol Moix, N; Santoro, Cristina; Cattaneo, M; Lavenu Bombled, C; Bury, L; Minuz, P; Nurden, P; Cid Haro, Ar; Cuker, A; Latger Cannard, V; Favier, R; Nichele, I; Balduini, Cl

BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS

2015 - HAEMATOLOGICA

Gresele, P; Noris, P; Orsini, S; Heller, P; Santoro, Cristina; Bury, L; Kadir, R; Mezzano, D; Falcinelli, E; Butta, N; Cid, Ar; Pozo, Jr; Miyazaki, K; Fabris, F; Fouassier, M; Flaujac, C; Ozdemir, Gn; Otomewo, O; Melazzini, F; Favier, R; Cattaneo, M; Bussel, J; De Maistre, E; Henskens, Y; De Candia, E; Bernejo, N; Schlegel, N.

HOW DIAGNOSTIC AND THERAPEUTIC APPROACHE CHANGED IN THE LAST DECADES IN THE PHILADELPHIA NEGATIVE MPN PATIENTS OF THE REGISTRO ITALIANO TROMBOCITEMIE (RIT)

2015 - HAEMATOLOGICA

Gugliotta, L; Iurio, A; Gugliotta, G; Tieghi, A; Candoni, A; Lunghi, M; Dragani, A; Antonioli, E; Scalzulli, Pr; Martinelli, V; Martino, B; Randi, Ml; Ricco, A; Appolloni, V; Maschio, N; Palmieri, R; Langella, M; Santoro, Cristina; Rago, A; Ragionieri, R; Codeluppi, K; Cacciola, E; Cacciola, R; Mastrullo, L; Esposito, Mr; Caocci, G; Lanza, F; Rupoli, S; Pierri, I; Porretto, F; Melpignano, A; Crugnola, M; Di Ianni, M; Plebani, S; Molinari, E; Spinosa, G; Santoro, M; Villani, O; Ricciotti, M; Musolino, C; Usala, E; Falzetti, F; De Biasi, E; Santoro, U; Federici, A; Vianelli, N; Mazzucconi, Maria Gabriella; Specchia, G.

ROLE OF TREATMENT ON THE DEVELOPMENT OF SECONDARY MALIGNANCIES IN PATIENTS WITH ESSENTIAL THROMBOCYTEMIA

2015 - HAEMATOLOGICA

Santoro, Cristina; Sperduti, I; Di Giandomenico, J; De Muro, M; Villiva, N; Di Veroli, A; Montanaro, M; Latagliata, R; Anaclerico, B; Giuseppe, A; Breccia, M; Cedrone, M; Cimino, Giuseppe; Felici, S; Crescenzi, Sl; Majolino, I; Montefusco, E; Montanaro, G; Porrini, R; Rago, A; Spadea, A; Spirito, F; Alimena, Giuliana; Andriani, A; Foa, Roberto; Mazzucconi, Maria Gabriella

HIGH DOSE SEQUENTIALCHEMOTHERAPY WITH RITUXIMAB AND ASCT AS FIRST LINE THERAPY IN ADULT MCL PATIENTS: CLINICAL AND MOLECULARRESPONSE OF THE MCL0208 TRIAL, A FIL STUDY

2015 - HAEMATOLOGICA20th Congress of European-Hematology-Association

Cortelazzo, S; Martelli, Maurizio; Ladetto, M; Ferrero, S; Ciccone, G; Evangelista, A; Mian, M; DI ROCCO, Alice; Chiappella, A; Rossi, G; Re, A; Zinzani, Pl; Balzarotti, M; Cavallo, F; Rusconi, C; Gotti, M; Arcaini, L; Gobbi, M; Gomes, M; Molinari, A; Liberati, Am; Michieli, M; Latte, G; Cabras, Mg; Novero, D; Paulli, M; Zamo, A; Chilosi, M; Federico, M; Vitolo, U.

THE IELSG-32 TRIAL: RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION VS HIGH-DOSE CHEMOTHERAPY SUPPORTED BY AUTOLOGOUS STEM CELLS TRANSPLANTATION FOR IMMUNOCOMPETENT PATIENTS WITH NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA

2015 - HAEMATOLOGICA45th Congress of the Italian-Society-of-Hematology

Ferreri, Ajm; Cwynarski, K; Pulczynski, E; Ponzoni, M; Politi, Ls; Ambrosetti, A; Vitolo, U; Ilariucci, F; Balzarotti, M; Fabbri, A; Tucci, A; Pisani, F; Levis, A; Cabras, Mg; D'Arco, M; Zaccaria, A; Angrilli, F; Guarini, Anna; Imola, M; Martelli, Maurizio; Cervetti, J; Zaja, F; Pinto, A; Liberati, M; Morra, E; Cortellazzo, Sf; Bassan, R; Foppoli, M; Citterio, G; Sassone, M; Scarfo, L; Cavalli, F; Finke, J; Reni, M; Zucca, E; Illerhaus, G.

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study

2015 - HAEMATOLOGICA

Rossi, D.; Bruscaggin, A.; La Cava, P.; Galimberti, S.; Ciabatti, E.; Luminari, S.; Rigacci, L.; Tucci, A.; Pulsoni, A.; Bertoldero, G.; Vallisa, D.; Rusconi, C.; Spina, M.; Arcaini, L.; Angrilli, F.; Stelitano, C.; Merli, F.; Gaidano, G.; Federico, M.; Palumbo, G. A.

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood

2015 - HAEMATOLOGICA

Aalbers, A. M.; Van Den Heuvel-Eibrink, M. M.; Baumann, I.; Dworzak, M.; Hasle, H.; Locatelli, F.; De Moerloose, B.; Schmugge, M.; Mejstrikova, E.; Novakova, M.; Zecca, M.; Michel Zwaan, C.; Te Marvelde, J. G.; Langerak, A. W.; Van Dongen, J. J.; Pieters, R.; Niemeyer, C. M.; Van Der Velden, V. H.

Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group

2015 - HAEMATOLOGICA

D'AngiÃ², M; Valsecchi, Mg; Testi, Anna Maria; Conter, V; Nunes, Vittorio; Parasole, R; Colombini, A; Santoro, N; Varotto, S; Caniglia, M; Silvestri, D; Consarino, C; Levati, L; Magrin, E; Locatelli, F; Basso, G; Foa, Roberto; Biondi, A; Cazzaniga, G.

Impact of maintenance therapy on subsequent treatment in patients with newly diagnosed multiple myeloma: use of "progression-free survival 2" as a clinical trial end-point.

2015 - HAEMATOLOGICA

Dimopoulos, Ma; Petrucci, Mt; Foa, Roberto; Catalano, J; Kropff, M; Terpos, E; Zhang, J; Grote, L; Jacques, C; Palumbo, A.

Long-term outcome of a phase 2 trial with nilotinib 400 mg twice daily in first-line treatment of chronic myeloid leukemia

2015 - HAEMATOLOGICA

Gugliotta, Gabriele; Castagnetti, Fausto; Breccia, Massimo; Levato, Luciano; DâAdda, Mariella; Stagno, Fabio; Tiribelli, Mario; Salvucci, Marzia; Fava, Carmen; Martino, Bruno; Cedrone, Michele; Bocchia, Monica; Trabacchi, Elena; Cavazzin, Francesco; Usala, Emilio; Rossi, Antonella Russo; Bochicchio, Maria Teresa; Soverini, Simona; Alimena, Giuliana; Cavo, Michele; Pane, Fabrizio; Martinelli, Giovanni; Saglio, Giuseppe; Baccarani, Michele; Rosti, Gianantonio